Novartis Investigative Site
Maribor 2000
0 studies enrolling now · 5 studies all time
What they study most
Breast Cancer, Cardiovascular Disease and Lipoprotein(a), Multiple Sclerosis, Neoplasms, Breast, Relapsing Multiple Sclerosis
Studies at this site
- Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) — Running, not enrolling
- The Gilenya Pregnancy Registry — Completed
- Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBC — Completed
- Lipoprotein(a) in Patients With Cardiovascular Disease (CVD) — Completed
- EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer — APPROVED_FOR_MARKETING